Provention Bio's J&J-licensed Crohn's drug stumbles in mid-stage study

Provention Bio's J&J-licensed Crohn's drug stumbles in mid-stage study

Source: 
Endpoints
snippet: 

One of the drugs that Oldwick, New Jersey-based Provention Bio joined forces with J&J on has failed a mid-stage study.